Trientine: Overview
Wilson's disease, a rare hereditary disorder that causes copper accumulation in the body, is treated with Trientine. The substance is also known by its chemical name, trientine tetrahydrochloride. The FDA cleared it for usage in 1985. This medication uses copper to create stable molecules that are then eliminated by urine. Trientine is frequently used when penicillamine, another medicine for Wilson's disease, is not tolerated or produces severe side effects. Trientine patients must be monitored continuously to reach the proper copper levels and control potential side effects.Contact The Indian Pharma for additional information on the medication's adverse effects and the Trientine cost.
















